Wnt-1 is dominant over neu in specifying mammary tumor expression profiles

Technol Cancer Res Treat. 2006 Dec;5(6):565-71. doi: 10.1177/153303460600500603.

Abstract

Wnt-1 and Neu collaborate to induce mammary tumors in bitransgenic mice carrying both MMTV-Wnt-1 and MMTV-Neu. In this report, gene expression profiles were determined for tumors from these bitransgenic mice, and compared with expression profiles of tumors from mice singly transgenic for MMTV-Wnt-1 or MMTV-Neu. While very different from tumors arising in MMTV-Neu transgenic mice, tumors from these bitransgenic mice were found not to have identifiable differences from tumors from MMTV-Wnt-1 transgenic mice, using clustering and multidimensional scaling analyses (unsupervised and supervised), One-way Analysis of Variance (ANOVA), and two sample t test (the later two of which were combined with false discovery rate computation). These observations suggest that Wnt-1 is dominant over Neu in specifying mammary tumor expression profiles.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Biomarkers, Tumor / genetics
  • Biomarkers, Tumor / metabolism*
  • Breast Neoplasms / genetics*
  • Breast Neoplasms / pathology
  • Female
  • Gene Expression Profiling*
  • Gene Expression Regulation, Neoplastic
  • Genes, Dominant*
  • Humans
  • Mammary Neoplasms, Animal / genetics*
  • Mammary Neoplasms, Animal / pathology
  • Mammary Tumor Virus, Mouse / genetics
  • Mice
  • Mice, Transgenic / genetics
  • Oligonucleotide Array Sequence Analysis
  • Receptor, ErbB-2 / genetics*
  • Wnt1 Protein / genetics*

Substances

  • Biomarkers, Tumor
  • Wnt1 Protein
  • Receptor, ErbB-2